Navigation Links
Fibroblasts invade at a snail's pace
Date:2/2/2009

A transcription factor known to drive the formation of fibroblasts during development also promotes their ability to invade and remodel surrounding tissues, report Rowe et al. in the February 9, 2009 issue of the Journal of Cell Biology.

The conversion of epithelial cells into fibroblast-like mesenchymal cells is a critical event in both normal development and cancer. The transcription factor Snail1 induces this conversion (known as epithelialmesenchymal transition, or EMT) by repressing the expression of epithelial-specific genes. Little was known about Snail1's role after EMT, although the transcription factor is up-regulated in mesenchymal tissue surrounding tumors and wounds.

Because Snail1 expression is thought to be required for maintenance of the mesenchymal phenotype in cancer, Rowe et al. were surprised to see that normal fibroblasts retained many mesenchymal characteristics when Snail1 was removed. The authors did find, however, that many genes important for cell motility, such as actin-binding proteins and matrix metalloproteinases, were expressed at lower levels in fibroblasts lacking Snail1.

Cells invade tissues by sending out actin-rich protrusions called invadopodia that contain proteolytic enzymes that degrade the surrounding extracellular matrix (ECM). Fibroblasts without Snail1 formed fewer invadopodia and were less able to degrade the ECM. Rowe et al. transplanted the Snail1-deficient fibroblasts into chick embryos and found that they were completely unable to penetrate the basement membrane and the complex mix of ECM proteins beneath. Moreover, unlike wild-type fibroblasts, Snail1-deficient cells didn't stimulate the ingrowth of new blood vesselsanother key function of fibroblasts during wound healing and tissue remodeling.

The team thinks that in addition to its role in EMT, Snail1 also acts as a master regulator of fibroblast function. In cancer cells, says author Grant Rowe, sustained Snail1 expression may not only cause a loss of epithelial markers but also promote tumor aggression by stimulating tissue invasion and angiogenesis.


'/>"/>

Contact: Rita Sullivan
rsullivan@rockefeller.edu
212-327-8603
Rockefeller University Press
Source:Eurekalert  

Related medicine news :

1. Radon: The Silent Home Invader That Can Kill
2. Cone snails and plants used to develop oral drug for pain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fibroblasts invade at a snail's pace
(Date:2/27/2017)... ... February 27, 2017 , ... This webinar , sponsored ... a tool to characterize particle size distributions in the field of geoscience and ... novel scientific findings. It describes methods of optimized and standardized sample collection, preparation ...
(Date:2/27/2017)... ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from ... scientific studies, the Center for Disease Control ( CDC ) and Infectious Diseases Society ... B. Liegner, M.D. has compiled into a single volume a compelling argument that the ...
(Date:2/27/2017)... ... February 27, 2017 , ... Sunshine Coast Health Centre ... Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of ... showcases the Centre's commitment to innovation in drug rehab and alcohol treatment strategies ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... and environs, is proud to announce an upgrade to the company's Yelp listing. ... Yelp page on topics as diverse as Platelet Rich Plasma (PRP) therapy, hair ...
(Date:2/26/2017)... , ... February 25, 2017 , ... The February 13, ... heightened awareness and concern over nerve agents and the deadly use of chemical weapons. ... nervous system and how even small doses can be lethal. , Jay Jagannathan, M.D., ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)...  Infinity Pharmaceuticals, Inc. (NASDAQ: INFI ) ... th Annual Healthcare Conference on Monday, March 6, ... MA. A live webcast of Infinity,s presentation ... website at www.infi.com , and will be available ... Infinity,Infinity is an innovative biopharmaceutical company dedicated to advancing ...
(Date:2/27/2017)... Inc. (NASDAQ: IPXL ) today announced that it plans to ... Raymond James and Associates, 38 th Annual Institutional Investors Conference ... FL. Cowen and Company 37 th ... in Boston, MA. Barclays Global ... Miami, FL. Individuals may listen to ...
(Date:2/27/2017)... -- A recent research report published by Grand View ... expected to reach a value of $55.8 billion by 2025. Earlier ... states have legalized marijuana for medical uses. In 2016, states such ... North Dakota , Ohio ... drug in medical applications such as chemotherapies and pain management. The ...
Breaking Medicine Technology: